Stocks

Singapore Markets Morning Briefing - what you need to know for Wed March 28, 2012

The STI faces strong downward pressure after moving back into the 3,000 zone, while the futures market points to a weaker opening.

Singapore Markets Morning Briefing - what you need to know for Wed March 28, 2012

The STI faces strong downward pressure after moving back into the 3,000 zone, while the futures market points to a weaker opening.

CapitaMalls Asia now a performance gauge of Hong Kong stock market

It has been selected as a constituent stock for both the Hang Seng Global Composite Index and the Hang Seng Foreign Companies Composite Index.

Singapore Markets Morning Briefing - what you need to know for Tues March 27, 2012

Equities, commodities, currencies, and treasuries all were impacted by FOMC Chair Ben Bernanke’s comments.

Singapore Markets Morning Briefing - what you need to know for Thurs March 22, 2012

Softer open for the STI is expected following muted reactions on Wall Street and the flat Nikkei start.

MAS and SGX join Malaysia and Thailand to expedite secondary listings review

Malaysia, Singapore and Thailand are the first three jurisdictions in ASEAN to satisfy the requirements of the framework.

Singapore Markets Morning Briefing - what you need to know for Tues March 20, 2012

Bullish market sentiment in the US could help see the STI recover after dropping below 3,000.

Singapore Markets Morning Briefing - what you need to know for Mon March 19, 2012

The STI pushed through the 3,000 mark, and traders are seemingly more bullish.

Singapore Markets Morning Briefing - what you need to know for Thurs March 15, 2012

There was mixed and muted reaction on Wall Street while China bore some bad news.

Singapore Markets Morning Briefing - what you need to know for Mon March 12, 2012

Modest gains closed the past week for US stocks, while the Nikkei is off to a positive start.

Singapore Markets Morning Briefing - what you need to know for Fri March 9, 2012

US stocks rallied overnight and the Nikkei gained 2%, along with the STI.